Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcription

Oncogene

Volumn 27, Issue 46, 2008, Pages 6044-6055

  Fukuyama, R ^a,d   Niculaita, R ^a,b   Ng, K P ^a   Obusez, E ^c   Sanchez, J ^a   Kalady, M ^a   Aung, P P ^a   Casey, G ^a,c   Sizemore, N ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

catenin; Colorectal cancer; MCC; Serrated; Wnt

Indexed keywords

B RAF KINASE; LYMPHOID ENHANCER FACTOR 1; T CELL FACTOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; EMBRYO; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; MOLECULAR BIOLOGY; MUTATED IN COLORECTAL CANCER GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BETA CATENIN; CACO-2 CELLS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COLORECTAL NEOPLASMS; COS CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 53649084334     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.204     Document Type: Article

References (36)

1. Agarwal A, Das K, Lerner N, Sathe S, Cicek M, Casey G et al. (2005). The AKT/I kappa B kinase pathway promotes angiogenic/ metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24: 1021-1031.
2. Ashton-Rickardt PG, Wyllie AH, Bird CC, Dunlop MG, Steel CM, Morris RG et al. (1991). MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene 6: 1881-1886.
3. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al. (2004). A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6: 97-105.
4. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. (2003). Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847-857.
5. Eleftheriou A, Yoshida M, Henderson BR. (2001). Nuclear export of human beta-catenin can occur independent of CRM1 and the adenomatous polyposis coli tumor suppressor. J Biol Chem 276: 25883-25888.
6. Fukuyama R, Ng KP, Cicek M, Kelleher C, Niculaita R, Casey G et al. (2006). Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Mol Carcinog 46: 402-413.
7. Gregorieff A, Clevers H. (2005). Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19: 877-890.
8. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
9. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H et al. (1991). Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
10. Henderson BR. (2000). Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2: 653-660.
11. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826.
12. Heyer J, Yang K, Lipkin M, Edelmann W, Kucherlapati R. (1999). Mouse models for colorectal cancer. Oncogene 18: 5325-5333.
13. Ishikawa S, Kobayashi I, Hamada J, Tada M, Hirai A, Furuuchi K et al. (2001). Interaction of MCC2, a novel homologue of MCC tumor suppressor, with PDZ-domain protein AIE-75. Gene 267: 101-110.
14. Ishitani T, Ninomiya-Tsuji J, Matsumoto K. (2003). Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol 23: 1379-1389.
15. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N et al. (1999). The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399: 798-802.
16. Jass JR. (2005). Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2: 398-405.
17. Jass JR. (2007). Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
18. Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VL, Gabrielli B et al. (2003). APC mutation and tumour budding in colorectal cancer. J Clin Pathol 56: 69-73.
19. Jass JR, Whitehall VL, Young J, Leggett BA. (2002). Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862-876.
20. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB et al. (1991a). Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665.
21. Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ et al. (1991b). Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251: 1366-1370.
22. Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, Dent OF et al. (2007). Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 26: 4435-4441.
23. Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A et al. (2006). Ascending the learning curve - MSI testing experience of a six-laboratory consortium. Cancer Biomarkers 2: 5-9.
24. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. (2004). Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6: 297-305.
25. Matsumine A, Senda T, Baeg GH, Roy BC, Nakamura Y, Noda M et al. (1996). MCC, a cytoplasmic protein that blocks cell cycle progression from the G0/G1 to S phase. J Biol Chem 271: 10341-10346.
26. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
27. Nourry C, Grant SG, Borg JP. (2003). PDZ domain proteins: plug and play! Sci STKE. http://stke.sciencemag.org/cgi/content/full/sigtrans; 2003/179/re7.
28. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. (2006). CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588.
29. Prall F, Ostwald C. (2007). High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. Hum Pathol 38: 1696-1702.
30. Rosin-Arbesfeld R, Townsley F, Bienz M. (2000). The APC tumour suppressor has a nuclear export function. Nature 406: 1009-1012.
31. Senda T, Matsumine A, Yanai H, Akiyama T. (1999). Localization of MCC (mutated in colorectal cancer) in various tissues of mice and its involvement in cell differentiation. J Histochem Cytochem 47: 1149-1158.
32. Shinto E, Tsuda H, Ueno H, Hashiguchi Y, Hase K, Tamai S et al. (2005). Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest 85: 257-266.
33. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. (2002). Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277: 3863-3869.
34. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al. (2006). CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
35. Zhang F, White RL, Neufeld KL. (2000). Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci USA 97: 12577-12582.
36. Zlobec I, Lugli A, Baker K, Roth S, Minoo P, Hayashi S et al. (2007). Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer. J Pathol 212: 260-268.